Multiple studies have demonstrated that mutations in CYP1B1 results in the loss of one or more of its enzymatic activity, stability and relative abundance [15]–[19] but no studies have been done yet to determine the mechanism operating in digenic scenarios in POAG cases involving both CYP1B1 and MYOC mutations. The gene discussed is CYP1B1; the disease is open-angle glaucoma.